Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.
Open | $0.20 |
Close | - |
Volume / Avg. | 1.32M / 1.68M |
Day Range | $0.19 - $0.20 |
52 Wk Range | 0.20 - 3.39 |
Market Cap | $4.46M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 2.23% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mainz Biomed (NASDAQ:MYNZ) through any online brokerage.
Other companies in Mainz Biomed’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and AquaBounty Techs (NASDAQ:AQB).
Mainz Biomed has a consensus price target of $7.00.
The stock price for Mainz Biomed (NASDAQ: MYNZ) is $0.204 last updated September 24, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Mainz Biomed.
Mainz Biomed’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Mainz Biomed.
Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.